UPDATE: Goldman Sachs Assumes Acceleron Pharma (XLRN) at Neutral
Tweet Send to a Friend
(Updated - March 22, 2021 5:18 AM EDT)
Goldman Sachs analyst Corinne Jenkins assumes coverage on Acceleron Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Corinne Jenkins assumes coverage on Acceleron Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
